Skip to content
Syndax Medical Affairs / Information
Ask a Question
Clinical Trials
Disease Information
Find your MSL
Footer
Header
No Access
Publications
Resources
Syndax Medical Affairs
Revumenib Monotherapy in NPM1m RR AML MED-REV-240026
npm1m; npm1; monotherapy;AUGMENT-101; NCT04065399; relapsed; refractory; aml; myeloid
February 22, 2025